版权说明:本文档由用户提供并上传,收益归属内容提供方,若内容存在侵权,请进行举报或认领
文档简介
IntroductionTreatmentofsymptomaticpatientswithHOCMaimstoreducesymptoms,improvefunctioncapacityandprovidebetterqualitylife.AimsdirectlytoreducethehypertrophiedinterventricularseptumwithconsecutiveexpansionoftheLVoutflowtractandreductionoftheLVoutflowtractgradientandimprovedistolicfunctionLV.Firstchoicedrugestreatment.
Atleast
10%
ofpatientswithmarkedoutflowtractobstructionhaveseveresymptoms,whichareunresponsivetomedicaltherapy.HOCMMyectomyDDD-PMICDPTSMAIntroductionTreatmentofsympt1HypertrophiccardiomyopathyEpidemiologicalcharacteristicsHypertrophiccardiomyopathyincidenceof0.2%(1:500),0.16%inourcountry
.Thevastmajorityofpatientswithnosymptoms,
25%ofoutflowtractobstructionoccurredonlyabout5-10%ofpatientswithdrugtreatmentsfailorcauseserioussideeffectsofdrugseffectivedose.Requiretreatmentorsurgicalinterventioninpatientstreatedwithonlyveryfewparts.
HypertrophiccardiomyopathyEp2PathophysiologicandclinicalcharacteristicsofHOCM
VentricularhypertrophyLeftventricularoutflowtractpressuregradientMyocardialischemia-anginapectoris.Arrhythmia-ventriculartachycardia,fibrillation.Clinicalmanifestations:dizziness,amaurosis,syncope,exertionalshortnessofbreath,anginapectoris,heartdisfunctionandsuddendeath.Generallyconsidered:moreseverehypertrophy,outflowtractobstructionneartheLVOTsit,themorehighertheobstructivepressuregradientwerethemoreobviousclinicalsymptomsandthegreaterthepotentialthreat.Pathophysiologicandclinical3ThenaturalcourseofoutflowtractobstructionLevel–anyages.thereisabigdifferenceinNaturalhistoryThenaturalcoursenotsure.Themorecardiachypertrophy,thehigherthepressuregradient,thegreatertheriskofsuddendeath.
Theoutflowtractpressuregradientoftheclinicalimportanceoftheissueremainscontroversial,butitisgenerallyconsideredanimportantclinicalprocessindicators.Nnualmortalityrateof2-4%,theincidenceof
suddendeath≤1%
Thenaturalcourseofoutflow4Thesymptoms
Whethertheobstructionproducedtheclinicalsymptoms?notonlywiththedegreeofoutflowtractobstructionandoutflowtractpressuregradient,aswellastheobstructionsite.Butalsowithventriculardiastolicfunctionandtheadequacyofvenousreturnisalsocloselyrelated.Increasetheheartbeforeandafterloadandmyocardialcontractilityoftencausenoticeableclinicalsymptoms.Therefore,itwillbecomemoreapparentafterexercise.Thepatientsshouldbetreatment.ThesymptomsWhethertheobs5Diastolicdysfunction
Allpatientshaddiastolicdysfunction–HowthepressuregradientandsymptomsAndtheextentanddistributionofthehypertrophyhasnothingtodo.Whethernormalorsmallventricularcavity,duetoincreasedheartweight,ventricularvolumereduction,myocardialfibrosis,leavingventricularstiffnessincreased,compliancedecreasedandcausedthediastolicfunctiondamage.Pulmonaryvenouspressureandend-diastolicpressure
wereincreasedandheartdisfunction.DiastolicdysfunctionAllpati6systolicfunctionSystolicfunctionisnormalorsupranormalinHCOMBothobstructionandnon-obstruction,Systolicdysfunctionoccursinsmallsubset(10-15%)
Resultofprogressiveimpairmentofsystolicfunction.Thistransformation:wallthinning,cavitydilation,andfibrosis,increasedmortality11%(annual)andriskofSCD.ConventionalUCG,M-mode,orEF,fractionalshorteningpreserveddespiteimpaimentlong-axisfunctionTissueDopplerimage(TD)-derivedsystolicvelocities:inthebasalinferoseptalandanterolateralwallroutinelyinallpatientsonsubsequentscans.systolicfunctionSystolicfunc7PTSMAindication(1)ClinicalindicationNodobutaminegradients(Drugs)CoronaryangiographyVerapamilRemoveballoonshouldbeemptyingalcoholoftheballooncatheterandstagnationinjectionalcoholOutflowtractobstructionsign
inEchocardiographSeptalthicknessHypertrophicCardiomyopathy
SurvivalAccordingtoOutflowTractGradientSystolicfunctionisnormalorsupranormalinHCOMMCEMorophologicindicationBeta-blockersasymmetricalseptalhypertrophy(ASH),2.Targetvesselsupplytonon-obstructionotherregionssuchas:papillarymuscle,freewall,etc.CONCLUSIONSBeta-blockersCONCLUSIONSCharacteristicsHypertrophiccardiomyopathyEpidemiologicalcharacteristicsMyocardialischemiaMyocardialischemia,thesymptomsofanginapectorisare:High-powersothatleftventricularmyocardialoxygenconsumptionincreased;Cardiaccontractionstrengthofoppressionthelargemyocardialcoronaryartery;Intramyocardialsmallcoronaryarterystenosisandintimalthickeningabnormalities,leadingtocardiachypertrophyandcoronaryarteryoxygenrequiredduetoanimbalanceofoxygensupply.PTSMAindication(1)Myocardia8Arrhythmiaandsuddendeath
HOCMofpatientswithabnormalmyocardialcellsandthearrangementofdisorderprovidesabasisforthearrhythmia.However,abnormalmyocardialarrangementandspontaneousarrhythmiasandventricularfibrillationthreshold,thepreciserelationshipisunclear.About25%ofpatientsmayhavenon-sustainedventriculartachycardia,thearrhythmiaissuddendeathofagoodpredictor,andnegativepredictiveaccuracyis97%.
ArrhythmiaandsuddendeathHO9RiskfactorsforsuddendeathHigh-risk:
1Suddendeathoccurredinasuccessfulrescue
2continuousmonomorphicventriculartachycardia
Clinicalriskfactors:
1non-sustainedventriculartachycardia
2movementabnormalbloodpressureresponse(≥25mmHg)
3unexplainedsyncope
4early-onsetfamilyhistoryofsuddendeath
5severeleftventricularhypertrophy>30mm
Riskfactorsforsuddendeath10ThepurposeofthetreatmentPTMSA
TreatmentofsymptomaticpatientswithHOCMThePTMSAtreatmentofHOCMisaobstructionbyblockingathesupplybloodofpartsoftheseptalhypertrophyofmyocardialandmyocardialinjuryintheregion,leadingtotheareaofmyocardialnecrosis,myocardialcontractilefunctiondisappeared,Widenedtheleftventricularoutflowtract,whileloweringtheoutflowtractobstructionandthecardiacoutputincrease.Andimproveclinicalsymptomsandhemodynamics.ThepurposeofthetreatmentP11PTSMAindication(1)ClinicalindicationSymptomaticpatientsDrugrefractoryseveresaideffectsmedicaltreatmentFunctionalclassIIIorIVFunctionalclassIIwithobjectivelimitationorriskfactorsRecurrentexercise-inducedsyncopesFailureofpriormyectomyorDDD-PMComorbitiywithincreasedsurgicalrisk.PTSMAindication(1)Clinical12PTSMAindication(2)HemodynamicindicationinsymptomaticpatientsThepressuregradientatrest>50mmHgor>100mmHgwithprovocation.In2008ESCmeeting,SeggewisethatLVgradient≧30mmHgatrestorProvocableLVgradient≧60mmHg.ValsalvaPostextrasystole.Nodobutaminegradients(Drugs)
(ThereisnoinformationthatreducetheLVOTpressuretoreducesuddendeath,buttheLVOT>30mmHgandincreasedriskofdeathdirectlyrelatedto,NewEnglJMed2003;348:295-303)
PTSMAindication(2)Hemodynam13HypertrophicCardiomyopathy
SurvivalAccordingtoOutflowTractGradientBJMaronetal;JAMA281:650-655,1999HypertrophicCardiomyopathy
S14PTSMAindication(3)MorophologicindicationEchocariography
SubaorrticSAM-associatedgradientMid-cavitarygradientCaution:papillarymuscleinvolvement:MCENoprolongedmitralleafletsCoronaryangiographysuitableseptalbranch.PTSMAindication(3)Moropholog15Outflowtractobstructionsign
inEchocardiographM-modeechocardiograminobstructivehypertrophiccardiomyopathyshowingsystolicanteriormotionofthemitralvalve(SAM)(arrowsindicatingseptumandmitralvalveleafletcontact)Outflowtractobstructionsign16
MorphologicofHOCMNewclassficationofHOCMMethods:theywereclassifiedinto4typesaccordingtotheechocardiographicresults:TypeI:localsubaorticobstructionofHOCM;TypeII:predominantinmidventicularobstruction;TypeIII:diffuseseptalhypertrophicobstructioninoutflowtractandmidventicularobstruction;TypeIV:multipositionhypertrophicobtruction.1.asymmetricalseptalhypertrophy(ASH),2.Idiopathichypertrophicsubaorticstenosis(IHSS),3.ApicalorJapaneseHCM.InthisformofnonobstructiveHCM,thethickestpartoftheleftventricleisatthetiporapexofthepump.4.theobstructionisnotintheoutflowtractbutinthemiddleoftheventricle.Atunnelleadsintoadilatedapicalportion,calledananeurysm,whichhasthinwalls.MorphologicofHOCM17OurclassficationinPTSMAOurtypingintheI-typeandMaronintheI-typingwasthesameassuitableforPTSMAtreatmentandMaron'sII-typeincludesthetypeIIandtype
IIIofourmodel,itissuitablePTSMAtreatment.Therefore,ourIV-typeclassificationisthefirstmadebyultrasoundimagingfeaturesofHOCM,accordingtoitscharacteristicsinlinewithPTSMAtreatment.OurclassficationinPTSMAO18ArrhythmiaandsuddendeathClinicalindicationSeptalAblationinHOCM
AcuteResults/AblationTechniquePathophysiologicandclinicalcharacteristicsofHOCMCharacteristics(post-PTSMA6months)Thevesselcannotthoroughorincompleteablation(remainingsmallerbranches),self-revascularization.SeptalthicknessCharacteristicsTransitorytrifascicularblocksoccurredatarateof52.(PG=80mmHg)DiltiazemThevesselcannotthoroughorincompleteablation(remainingsmallerbranches),self-revascularization.ResultsofPTSMASeptalthicknessHypertrophicCardiomyopathy
SurvivalAccordingtoOutflowTractGradientIncreasetheheartbeforeandafterloadandmyocardialcontractilityoftencausenoticeableclinicalsymptoms.Complicationsinourpatientsasymmetricalseptalhypertrophy(ASH),2.Mergeotherneedssurgeryheartdisease
Mitralvalveabnormalitiesandtheirownformofpapillarymusclesinvolvedintheformationofpressuregradient,ormitralvalveprolapseandregurgitation.PTSMAcontraindicationsTarget
vessel
Selectablationofregionalimportance,particularlyinthetargetvesselisnotclearwhotheseptalbranch
Thefirstseptalbranchofthesizeanddistributionaregreatvariation
20%ofpatientsfirstbranchwassuppliedthefreewallofrightventricle
40%ofpatientswithsubaorticofseptalisnotcompletelysupportedbythefirstseptalbranch
5%ofpatientscannotdeterminethetargetvesseloftheregionArrhythmiaandsuddendeathTar19Contrastechocardiographymethod
inthetargetvesse
choiceInjectionofasmallamountofdye(1-2ml)throughtheguidewirelumenoftheinflatedballooncatheterangiographicallyPriortoalcoholinjection1-2mlofechocontrastmediumisadministeredthroughthecentrallumenoftheballooncatheterunderUCG.determinesthesupplyareaofthetargetseptalbranch.Ensurethatnoareasinvolvingnon-obstructive,suchasthepapillarymusclesandventricularfreewallandotherparts.Contrastechocardiographymeth20Myocardial-Contrast-Echo
inHOCM
AvoidLADballooningExcludeLADleakageMyocardial-Contrast-Echoi21SeptalAblationinHOCM
Myocardial-Contrast-EchoLevovist
Intheintervalofcontrastagentinjectedintothebranchtoobservethedistributionofvascularcontr
Alcohol
ShadowSeptalAblationinHOCM
Myocar22
LevovistshadowLevovistshadow23Echosequence:SubaorticseptumastargetbregionintypicalSAM-associated,subaorticobstraction,(Ddottedline),EtestinjectionoftheechocontrastagentinballoonofthethefirstsetalbranchofaforwardbranchofpositionhighlightingbebasalhalfofseptumplusaRVpapillarymuscle(whitearrows).Aftersuper-selectiveballoonofotherbranchoffirstseptalbranch.Correctopacification.Echosequence:Subaorticseptu24MCEN=222NoMCEn=30PSeptalbranches(n)1.0±0.11.3±0.2<0.0001Alcohol(ml)2.9±0.93.9±2.4<0.0001Balloonsize(mm)1.9±0.42.4±0.2<0.0001CKmax(U/l)534±248745±420<0.001CK-MBmax(U/l)62±3096±62<0.0001H.Seggewissetal,49thScientificSessionsACC,2000SeptalAblationinHOCM
AcuteResults/AblationTechniqueMCENoMCEPSeptalbranches(n)125H.Seggewissetal,49thScientificSessionsACC,2000SeptalAblationinHOCM
AcuteResults/AblationTechniquep<0.05p<0.01H.Seggewissetal,49thScien26keysofTechnologyofPTSMA
Thekeytechnology:
identificationThepressuregradientatsubaorticandleftventricularidentificationsuitableoftargetseptalbranches.Mustbeinsertedtemporarypacemaker(topreventtheconductionblock).
Simultaneousmonitoringofaorticandleftventricularpressure.
Heparin(topreventcatheterinducedthrombosis).
AnalgesicGuidingcatheter:supportingflexibleandlowinjurySuitableOver-the-wireballooncatheterkeysofTechnologyofPTSMATh27ThekeysofTechnology
PTSMAIntraoperativeultrasoundmonitoringContrastechocardigraphyPaycloseattentiontothepressuregaugeunderfluoroscopy(observationballoonexpansionofstate).Injectionofalcoholdoseandspeeddeterminewhethershouldinjury(catheteroralcohol)andtheintervalbranchblock(necrosisstate)conditions1(withcomplications)or2septalbranches
ablationdidnotsignificantlyreducethepressure,andnoincreasealcoholdoseRemoveballoonshouldbeemptyingalcoholoftheballooncatheter
andstagnationinjectionalcoholThekeysofTechnologyPTSMAIn28(pre-PTSMA)Septalthickness(post-PTSMA3days)Mid-cavitarygradientTargetvesselsupplytonon-obstructionotherregionssuchas:papillarymuscle,freewall,etc.Priortoalcoholinjection1-2mlofechocontrastmediumisadministeredthroughthecentrallumenoftheballooncatheterunderUCG.Outflowtractobstructionsign
inEchocardiographAcutemitralregurgitationalsodidnotoccur.CONCLUSIONS43monthslater,90%ofthepatientsofthepressuregradientcompletelyeliminatedbyechocardiographic5mmandtoolong.MorphologicofHOCMTransitorytrifascicularblocksoccurredatarateof52.EchocariographyClinicalmanifestations:dizziness,amaurosis,syncope,exertionalshortnessofbreath,anginapectoris,heartdisfunctionandsuddendeath.Contrastechocardiographymethod
inthetargetvessechoiceClinicalindicationOutflowtractobstructionsign
inEchocardiographResultsofPTSMASystolicfunctionisnormalorsupranormalinHCOMSeptalthicknessContrastechocardigraphyAvoidLADballooningHypertrophiccardiomyopathyEpidemiologicalcharacteristicsContrastechocardiographycannotdeterminetargetvesselortheobstructionofregionalnosuitabletargetvessel.Doseofalcoholandspeed.(ThereisnoinformationthatreducetheLVOTpressuretoreducesuddendeath,buttheLVOT>30mmHgandincreasedriskofdeathdirectlyrelatedto,NewEnglJMed2003;348:295-303)FunctionalclassIIIorIVdeterminesthesupplyareaofthetargetseptalbranch.DDD-pacemaker:2-10%ResultsofPTSMAComplicationsinourpatientsApicalorJapaneseHCM.CharacteristicsThevesselcannotthoroughorincompleteablation(remainingsmallerbranches),self-revascularization.MorophologicindicationSystolicfunctionisnormalorsupranormalinHCOMThemorecardiachypertrophy,thehigherthepressuregradient,thegreatertheriskofsuddendeath.HypertrophicCardiomyopathy
SurvivalAccordingtoOutflowTractGradientClinicalindicationMustbeinsertedtemporarypacemaker(topreventtheconductionblock).(pre-PTSMA)A51-year-oldwoman’sLVOTgradientwasmonitoredcontinuouslyjustbeforetheballoonocclusion.(PG=80mmHg)LVAO(pre-PTSMA)Contrastechocardig29HerLVOTgradient10minutesafterseptalablation(PG=12mmHg)LVAOHerLVOTgradient10minutesa30A36-year-oldman’sLVOTgradienttestedbyDopplerechocardiographybeforePTSMA(PG=219mmHg)A36-year-oldman’sLVOTgradi31HisLVOTgradient6monthsafterPTSMA(PG=15mmHg)HisLVOTgradient6monthsaft32经皮间隔支化学消融治疗肥厚梗阻性心肌病英文课件(模板)33经皮间隔支化学消融治疗肥厚梗阻性心肌病英文课件(模板)34经皮间隔支化学消融治疗肥厚梗阻性心肌病英文课件(模板)35PG120mmHgbeforeprocedurePG120mmHgbeforeprocedure36PG=40mmHgafterinjectionof4.8mlalchoholPG=40mmHgafterinjectionof437GreatattentionEchocardiographyshowedventricularseptalhypertrophyover30mminHOCM,necessarytoperformeingPTSMAshouldbeverycautiousandcareful.Maybetherewereathickseptalbranch,andcontrolwide,and
collateral-richseptalbranchofsupport,treatmenthadahigherriskandimprovetheclinicalsymptomsandhemodynamicshavedifficulties,sosurgerymytomcemaybeabetterchoice.GreatattentionEchocardiog38Itisverybigseptalbranch>2.5mmandtoolong.ThereisquitedangertoPTMSAItisverybigseptalbranch>39PTSMAcontraindications
Nosignificantpressuregradientinhypertrophiccardiomyopathyorverydiffuseobstructive.
Mergeotherneedssurgeryheartdisease
Mitralvalveabnormalitiesandtheirownformofpapillarymusclesinvolvedintheformationofpressuregradient,ormitralvalveprolapseandregurgitation.
Contrastechocardiographycannotdeterminetargetvesselortheobstructionofregionalnosuitabletargetvessel.
Targetvesselsupplytonon-obstructionotherregionssuchas:papillarymuscle,freewall,etc.
NotsuitableOver-the-wireballoon.PTSMAcontraindicationsNosig40PTSMAcomplications(1)
Hospitalmortalityrate:1-2%DDD-pacemaker:2-10%
Myocardialinfarction
Reason:alcoholleakageintothepartsofinappropriate,collateralbranchopening,alcoholintotheinappropriatepartscauseno-reflow,LAD/LM/RCAinjury
Emergencysurgery
Reason:coronaryarteryinjury,acutemitralregurgitation(papillarymusclerupture)Bundlebranchblock:about50%andRBBB-basedPTSMAcomplications(1)Hosp41PTSMAcomplications(2)
HeightorIII°-AVB
Factors:
whetherthemethodofapplicationofmyocardialcontrastechocardiography.
Doseofalcoholandspeed.Leftanteriordescendingarterydissection,coronarythrombosis,ventricularfibrillationandventriculartachycardia,acutemitralregurgitation,rightventricularinfarction,leftventricularfreewallinfarction.PTSMAcomplications(2)Heig42PTSMAshortcomings
Injuryoftheleftcoronaryarteryrequiredemergencybypassorstent
Cannotenterthetargetseptalbranch
CannotdeterminethetargetbranchofsupportFormitralandpapillarymuscleanomaliesandabnormalseptalhypertrophythebestchoicethesurgery
Mitralvalveinjuryrequiredemergencysurgery.
PermanentconductionblockoccurstreatmentshouldbePMPTSMAshortcomingsInjuryoft43Theseptalbranchwithgoodcollateralcirculation.DiastolicdysfunctionBeta-blockersThevastmajorityofpatientswithnosymptoms,PTSMAcomplications(2)(post-PTSMA3days)PTSMAindication(3)EchocardiographicobservationsplaysanimportantroleinthatwillhelptofinalizedefinethechoiceofseptalablationandtheablationefficacyandreducerisksandLong-termfollow-upoftreatmentefficacy.ComplicationsinourpatientsPG120mmHgbeforeprocedureFunctionalclassIIwithobjectivelimitationorriskfactorsClinicalindicationPatients(n=171)EchocariographyGenerallyconsidered:moreseverehypertrophy,outflowtractobstructionneartheLVOTsit,themorehighertheobstructivepressuregradientwerethemoreobviousclinicalsymptomsandthegreaterthepotentialthreat.DiltiazemHOCMMyectomyFormitralandpapillarymuscleanomaliesandabnormalseptalhypertrophythebestchoicethesurgery59%)underwentpermanentpacemakerimplantationduetopermanentcompleteAVblock.VerapamilMyocardial-Contrast-EchoinHOCMHerLVOTgradient10minutesafterseptalablation(PG=12mmHg)PTSMAlimitations
Someyoungpatientstoreducethepressuregradienteffectisnotsatisfactory,thepossiblereasons:Theseptalbranchwithgoodcollateralcirculation.Thevesselcannotthorough
orincompleteablation(remainingsmallerbranches),self-revascularization.Ahigherdegreeofseptalhypertrophy,ahigherdegreeoffibrosis,Partsoftheseptalablationscarformationpoor.
Theseptalbranchwithgoodco44PTSMAin
FuwaiHospitalFromDec2000toMay2009,171patientsunderwentPTSMAinFuwaiHospital.Proceduresuccesswasachievedin141patients,successratewas82.6%.PTSMAin
FuwaiHospitalFrom45PatientCharacteristicsCharacteristicsPatients(n=171)Age(yrs)45.37±17.71Men/women122/49(71.35%/28.65%)SymptomsDyspnea93(54.39%)Angina73(42.69%)Syncope76(44.44%)NYHAfunctionalclass(II/III/IV)136(79.53%)/32(18.72%)/3(1.75%)Familyhistory42(24.6%)MedicationBeta-blockers106(62%)Verapamil52(30.4%)Diltiazem38(22.2%)Amiodanone13(7.6%)PatientCharacteristicsCharact46ResultsofPTSMAPTSMA(n=171)pSeptalthickness(pre-PTSMA)22.67±5.35mm
Septalthickness(post-PTSMA3days)20.68±4.61mmNSSeptalthickness(post-PTSMA6months)16.77±4.39mm<0.05LVOTPG(pre-PTSMA)97.58±38.23mmHgLVOTPG(post-PTSMA3days)52.36±35.7mmHg<0.001LVOTPG(post-PTSMA6months)47.26±38.62mmHg<0.001LADiameter(pre-PTSMA)43.78±7.33mm
LADiameter(post-PTSMA3days)42.41±7.52mmNSLADiameter(post-PTSMA6months)32.76±15.58mm<0.05ResultsofPTSMAPTSMA(n=171)p47ComplicationsinourpatientsIn-hospitaldeath
UptoMay2009,twopatientsdiedinthose171patients(1.17%)whounderwentPTSMAinFuwaiHospital.OnewasbecauseofalcoholleakagetotheLeftanteriordecendingartery,anotheroccurreddrug-inducedliverinjury.CompleteheartblockTransitorytrifascicularblocksoccurredatarateof
52.05%(89patients).
Onlyonepatient(0.59%)underwentpermanentpacemakerimplantationduetopermanentcompleteAVblock.ComplicationsinourpatientsI48ComplicationsinourpatientsOnepatient(0.59%)occurredventricularfibrillation,butherecoveredwellaftertheprocedure.Rightbundlebranchblockoccurredatarateof48.54%(83in171patients).NodissectionsoftheLMandLAD.NoemergencyCABGAcutemitralregurgitationalsodidnotoccur.ComplicationsinourpatientsO49Follow-upinourpatientsbyecho
Leftventricularoutflowtractpressuregradientwascontinuedtoasignificantdecreaseisanimportantfeature:Comparedwiththeacutephase,56%ofpatients3monthsrestingandstimulatethepressuregradientwillcontinuetodeclinefurther;Comparedwith3-monthperiod,43%ofpatientsoneyearthepressuregradientisstillfurtherreduced.After
3months40%ofpatientswithpressuregradientcompletelyreduced,ayearlaterthisvaluewaspromotedto62%.43monthslater,90%ofthepatientsofthepressuregradientcompletelyeliminatedbyechocardiographicFollow-upinourpatientsbye50CONCLUSIONSPTSMAisaneffectivenon-surgicalprocedureforsymptomaticpatientsandassociatedwithLVOTOinHOCMbecauseofitslowriskanditssignificanthemodynamicandsymptomaticimprovement.Ablationareashouldbeappropriate,assmallaspossible,toavoidalargescarformation.EchocardiographicobservationsplaysanimportantroleinthatwillhelptofinalizedefinethechoiceofseptalablationandtheablationefficacyandreducerisksandLong-termfollow-upoftreatmentefficacy
.CONCLUSIONSPTSMAisaneffecti51Advice
Whohavenosymptomsormildsymptomsofthepatient,determinednottoconsiderthelinetoreduceoutflowtractobstructionofanytherapeuticinterventionmeasures(includingsurgicalandinterventionaltreatment)!!!AdviceWhohavenosymptoms52经皮间隔支化学消融治疗肥厚梗阻性心肌病英文课件(模板)53PTSMAindication(1)ClinicalindicationSymptomaticpatientsDrugrefractoryseveresaideffectsmedicaltreatmentFunctionalclassIIIorIVFunctionalclassIIwithobjectivelimitationorriskfactorsRecurrentexercise-inducedsyncopesFailureofpriormyectomyorDDD-PMComorbitiywithincreasedsurgicalrisk.PTSMAindication(1)Clinical54PTSMAindication(2)HemodynamicindicationinsymptomaticpatientsThepressuregradientatrest>50mmHgor>100mmHgwithprovocation.In2008ESCmeeting,SeggewisethatLVgradient≧30mmHgatrestorProvocableLVgradient≧60mmHg.ValsalvaPostextrasystole.Nodobutaminegradients(Drugs)
(ThereisnoinformationthatreducetheLVOTpressuretoreducesuddendeath,buttheLVOT>30mmHgandincreasedriskofdeathdirectlyrelatedto,NewEnglJMed2003;348:295-303)
PTSMAindication(2)Hemodynam55HypertrophicCardiomyopathy
SurvivalAccordingtoOutflowTractGradientBJMaronetal;JAMA281:650-655,1999HypertrophicCardiomyopathy
S56A36-year-oldman’sLVOTgradienttestedbyDopplerechocardiographybeforePTSMA(PG=219mmHg)A36-year-oldman’sLVOTgradi57PTSMAcontraindications
Nosignificantpressuregradientinhypertrophiccardiomyopathyorverydiffuseobstructive.
Mergeotherneedssurgeryheartdisease
Mitralvalveabnormalitiesandtheirownformofpapillarymusclesinvolvedintheformationofpressuregradient,ormitralvalveprolapseandregu
温馨提示
- 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
- 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
- 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
- 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
- 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
- 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
- 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。
最新文档
- 2024-2030年中国果品加工行业产销量预测及未来五发展趋势报告
- 玻璃制造中的电镀和涂层技术考核试卷
- 海水养殖场景的环境友好型农业考核试卷
- 2024-2030年中国曲屏电视行业市场竞争趋势及发展潜力分析报告
- 2024-2030年中国无轨电车行业产销形势及投资策略分析报告版
- 2024-2030年中国教学无线扩音机项目可行性研究报告
- 2024商用土地与建筑租赁协议样本
- 2024至2030年中国搁酒架数据监测研究报告
- 2024-2030年中国扫雪车产业经营策略分析及未来发展规划研究报告
- 2024-2030年中国手提式氧气发生器行业市场运营模式及未来发展动向预测报告
- 单元主题-生物体的结构层次教学设计
- 三年级数学(上)计算题专项练习附答案集锦
- 2024公安机关人民警察高级执法资格考试题(解析版)
- 2024年国家公务员考试行测真题及答案(完整版)
- 质量为纲-华为公司质量理念与实践
- 17难忘的泼水节第一课时公开课一等奖创新教学设计
- 大一统王朝的巩固(课件) 2024-2025学年七年级历史上册同步教学课件(统编版2024)
- 课件第一章第1节动量定理(16张)
- 2024年银行合规心得体会(五篇)
- 水生产企业(自来水公司)水务安全生产三项制度(安全生产责任制、制度、操作规程)汇编
- 加强学校食堂管理提高食品安全意识(培训课件)
评论
0/150
提交评论